S Kirschenbaum
About
In The Last Decade
S Kirschenbaum
9 papers receiving 703 citations
Peers
Comparison fields: 5 of 74
- Molecular Biology 576
- Oncology 342
- Toxicology 141
- Organic Chemistry 104
- Cardiology and Cardiovascular Medicine 57
Countries citing papers authored by S Kirschenbaum
This map shows the geographic impact of S Kirschenbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Kirschenbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Kirschenbaum more than expected).
Fields of papers citing papers by S Kirschenbaum
This network shows the impact of papers produced by S Kirschenbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Kirschenbaum. The network helps show where S Kirschenbaum may publish in the future.
Co-authorship network of co-authors of S Kirschenbaum
This figure shows the co-authorship network connecting the top 25 collaborators of S Kirschenbaum. A scholar is included among the top collaborators of S Kirschenbaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Kirschenbaum. S Kirschenbaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA. | 202 |
| 2 | DNA topoisomerase I-mediated DNA cleavage and cytotoxicity of camptothecin analogues. | 307 |
| 3 | Resistance of human leukemic and normal lymphocytes to drug-induced DNA cleavage and low levels of DNA topoisomerase II. | 143 |
| 4 | Metabolic activation of N-acylanthracyclines precedes their interaction with DNA topoisomerase II. | 11 |
| 5 | 9 | |
| 6 | Effects of new N-alkyl analogues of adriamycin on in vitro survival and cell cycle progression of L1210 cells. | 12 |
| 7 | Relationship of adriamycin concentrations to the DNA lesions induced in hypoxic and euoxic L1210 cells. | 41 |
| 8 | Relationship of adriamycin concentration to induced dna lesions in hypoxic and euoxic l1210 cells. Abstr. | 2 |
| 9 | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.